KLK14 as a novel therapeutic target in muscle wasting induced by androgen deprivation therapy

This project aims to determine if the PSA-related protease, KLK14, induces muscle wasting in men on androgen deprivation therapy (ADT) and determine the underlying mechanisms involved in this process.

  This study will determine:

  1. the expression levels of KLK14 in muscle biopsies from men with prostate cancer, both ADT treatment naive and on ADT;

  2. the regulatory response of KLK14 in a human skeletal muscle cell line to androgen stimulation (DHT) and the anti-androgens, bicalutamide and enzalutamide to mimic the clinical ADT setting;

  3. the mechanisms of KLK14 mRNA induction and downstream consequences of KLK14 action that drives the skeletal muscle microenvironment remodelling in ADT.



Judith Clements APCRC-Q, IHBI, QUT, TRI



2016 - 2016


Prostate Cancer Foundation of Australia $99 732

Upcoming Events

Feb 09, 2020 - Feb 13, 2020 ICONN 2020
Brisbane Convention and Exhibition Centre, Queensland
Feb 13, 2020 - Feb 15, 2020 ASCO Genitourinary Cancers Symposium 2020
Moscone West Building, San Francisco, USA
Mar 07, 2020 - Mar 10, 2020 USANZ 2020 Annual Scientific Meeting
International Convention Centre, Sydney, New South Wales
Mar 20, 2020 - Mar 24, 2020 EAU Congress 2020
RAI Amsterdam, The Netherlands
Mar 25, 2020 - Mar 29, 2020 World Science Festival Brisbane